Intel Stock Surges 6% as Chip Rally Reignites After Five-Day Losing Streak
Mondeum Capital (UK) Limited

Intel shares have rebounded. By midafternoon Wednesday, the stock was up almost 6%, building on Tuesday’s 2.4% gain and ending a five-day slide that had erased 16% of its value. For investors worried the drop might last, Wednesday’s rally suggests otherwise. Here’s what’s behind the recovery and why Wall Street analysts are raising their price targets, even as some worry that certain chip stocks may be overvalued.
Intel’s stock has risen over 200% this year, and other semiconductor stocks also climbed on Wednesday. AMD gained 7.5%, Qualcomm rose 3.5%, Micron added 4.1%, and Marvell was up 4.7%. This shows that investors are once again interested in chip stocks after the recent decline.
Wall Street analysts stayed confident during the losing streak. A Seaport analyst admitted that some chip stocks may be overvalued but believes Intel can grow into its current price. Benchmark raised its price target to $140 from $105 on Monday, after talking with company management boosted their confidence that Intel’s earnings potential is being underestimated.
Citi also increased its price target to $130 from $95 earlier this week. The firm expects the central processing unit market to grow 35% each year and reach $132 billion by 2030, thanks to rising demand from AI agent workloads. This strong long-term outlook supports the bullish view on Intel, and Wednesday’s rally shows that investors are ready to back it again.
Recent news

IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]

Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]

Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.
Featured Courses